DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Havrix (Hepatitis A Vaccine (Inactivated)) - Current Clinical Trials


Havrix Related Clinical Trials

Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs [Recruiting]

The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines [Completed]

Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine [Completed]

Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines [Completed]

HIV and Hepatitis Care Coordination in Methadone Treatment [Completed]

Study of Evaluating Safety and Immunogenicity of 10�g/0.5ml Hepatitis B Vaccine [Completed]

Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery [Not yet recruiting]

Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients [Completed]

PCV13 + Hepatitis A Vaccine for Adults [Not yet recruiting]

Hepatitis A Vaccine in Patients With Immunomodulating Drugs [Completed]

A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A [Completed]

Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children [Completed]

Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation [Completed]

De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation [Recruiting]

The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines [Active, not recruiting]

Role of Cytokines in Hepatitis E Virus Infection During Pregnancy [Completed]

Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2) [Terminated]

Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta [Recruiting]

A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV) [Completed]

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule [Completed]

Observational Study of Immune Response to Hepatitis B Childhood Booster [Completed]

Acceptability of Hepatitis B Vaccination in General Population [Completed]

Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease [Completed]

Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C [Completed]

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection [Completed]

Immunogenicity and Safety of Vaccinations in Immunocompromised Persons [Recruiting]

Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV . [Recruiting]

Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C [Recruiting]

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule [Completed]

Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity [Enrolling by invitation]

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients [Active, not recruiting]

A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection [Completed]

Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths [Completed]

A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection [Completed]

Duration of Long-term Immunity After Hepatitis B Virus Immunization [Completed]

Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin [Completed]

Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206) [Terminated]

Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters [Recruiting]

Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine [Completed]

Hepatitis C in Renal Transplant Recipients [Active, not recruiting]

Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load [Active, not recruiting]

Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders [Recruiting]

Hepatitis C Treatment in Underserved Populations [Enrolling by invitation]

Therapeutic Option for Hepatitis B and C: a French Cohort [Recruiting]

Rapid Diagnostics for HIV and Hepatitis [Recruiting]

The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates [Completed]

Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma [Active, not recruiting]

New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C [Recruiting]

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults [Completed]

Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib [Completed]

Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib [Completed]

Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy [Recruiting]

Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection [Enrolling by invitation]

Epidemiological Study in Children and Adolescents With Chronic Hepatitis B [Completed]

An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users [Completed]

Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects [Terminated]

Immune Cell Dysfunction in Severe Alcoholic Hepatitis [Recruiting]

The Hepatitis Delta International Network [Recruiting]

Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules [Completed]

Hepatitis B Acceptability and Vaccination Incentive Trial [Completed]

Epidemiological Study to Evaluate the Management of Patients With Chronic Hepatitis C and Previous Treatment Failure [Active, not recruiting]

Hepatitis C Translating Initiatives for Depression Into Effective Solutions [Active, not recruiting]

Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose [Completed]

Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin [Recruiting]

Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U) [Recruiting]

A Two Part, Open-label Study to Evaluate the Safety and Effectiveness of ABT-450/r/ABT-267 or ABT-450/r/ABT-267 and ABT-333 Given With or Without a Drug Called Ribavirin in People With Both Hepatitis C Virus Genotype 1 or 4 Infection and Human Immunodeficiency Virus, Type 1 Infection [Recruiting]

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection [Terminated]

Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients [Recruiting]

Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors [Not yet recruiting]

A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection [Completed]

Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients [Active, not recruiting]

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants [Completed]

Q-Trial in Patients With Hepatitis C [Completed]

Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age [Completed]

Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C [Terminated]

Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B [Completed]

A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients [Completed]

Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) [Completed]

Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis [Completed]

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand [Recruiting]

Investigation of Hepatitis B and Hepatitis C in Taiwan [Completed]

Response to Hepatitis B Vaccine in Celiac Disease Patients [Terminated]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017